Emerging research is investigating the impact of diet on cancer treatment and lengthening survivorship. These studies have hypothesized that certain types of cancer are metabolic diseases and should use therapies that treat it as such. A metabolic disease is any disease or disorder affecting the metabolism from functioning normally, affecting how food is converted to energy on a cellular level. Cancer cells prefer to convert glucose (sugar) to energy. Normal cells, however, use oxidative phosphorylation, which is a much more efficient process. Some studies suggest that cancer cells thrive on a high-glucose (sugar) environment but become vulnerable when they are deprived of glucose.

Our team has shared their experience with a metabolic diet during and after medical treatment for Glioblastoma with our Tips for Metabolic-Immunity Health.

Glioblastoma is an aggressive brain cancer with a typical survival time of just 12–15 months.

In a new study, “Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study,” the role of ketogenic diet after medical treatment was statistically significant.

These results suggest that the ketogenic diet may have helped extend some patients’ lives.

The outcomes observed in these patients offer promising insights into the potential benefits of the ketogenic diet on the progression of glioblastoma multiforme when compared to those who did not follow the diet consistently.

To read about the study – click here.

‍